Navigation Links
Targeting the protein AEG1 impairs human liver cancer growth in mice
Date:2/16/2009

Hepatocellular carcinoma (HCC) is a highly aggressive form of liver cancer and one of the 5 most common cancers worldwide. Devanand Sarkar and colleagues, at Virginia Commonwealth University School of Medicine, Richmond, have now identified a gene that is expressed at high levels in human HCC tumor samples and generates a protein important for HCC progression. They therefore suggest that targeting this gene (AEG1), or the protein that it generates, might provide a new therapeutic strategy for the treatment of HCC.

In the study, human liver cells were found to express only low levels of the protein AEG1, whereas human HCC tumor samples expressed very high levels. This was associated with an increase in the number of copies of the AEG1 gene in human HCC tumor samples. Functionally, human liver cell lines engineered to overexpress AEG1 grew faster than nonengineered cells and developed into highly aggressive tumors when transplanted into mice. In addition, knocking down levels of AEG1 in human HCC cell lines after they had been allowed to form a tumor in mice limited further growth. Further analysis revealed that the effects of AEG1 were mediated, in part, via its ability to activate the Wnt signaling pathway.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Tobacco Companies Targeting Teens, Study Says
2. APIC 2009 Targeting Zero Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
3. Targeting Cancers Own Stem Cells to Fight Recurrence
4. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
5. Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic
6. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
7. EGFR-targeting antibody licensed to Abbott
8. Tackling a hard-to-treat childhood cancer by targeting epigenetic changes
9. Tackling Hard-to-treat Childhood Cancer by Targeting Epigenetic Changes
10. NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African-American Voters
11. Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... The Spiritual Care Association (SCA) ... their valuable support to patients and their families, and their overall contribution to the ... Spiritual Care Day, SCA has sent “Thank You Chaplain” cards with hand-painted artwork to ...
(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... ... Washington Wellness Center today announced its tenth anniversary of providing a complete ... as an idea to provide a holistic approach to wellness has now become a ... David Swanekamp, Chiropractic Physician , the wellness center offers a complete range of ...
(Date:5/4/2016)... ... 2016 , ... Dr. Elyson and Dr. Assili, dentist in Northridge , ... tooth removal, a common dental procedure, is performed for many adolescents and young adults ... in risks of complications. By providing wisdom tooth removal surgery at their office, Dr. ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Recognizing that ... launched health brand, Verywell, have tapped David Katz, MD, MPH, president of ... , “Our shared devotion to lifestyle medicine is especially gratifying,” said Katz. “There is ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016  It,s time for an upgrade. There are many medical recorders on the ... LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a ... class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... 4, 2016 Valeritas Holdings, Inc. ... alternative public offering (APO). This was accomplished via a ... Inc. and a private placement of approximately 5 million ... share. Under the terms of the reverse ... Holdings, Inc. will trade on the OTC Markets under ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
Breaking Medicine Technology: